𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-viral effect of recombinant interferon alfa-2a on hepatitis C virus

✍ Scribed by YOKOSUKA, O; OMATA, M; HOSODA, K; KATO, N; OHTO, M

Book ID
122914479
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
248 KB
Volume
1
Category
Article
ISSN
0928-4346

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatitis C virus dynamics in vivo: Effe
Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover
✍ Prof. med. Stefan Zeuzem; JΓΌrgen M. Schmidt; Jung-hun Lee; Michael von Wagner; G πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 187 KB πŸ‘ 1 views

Treatment of patients with chronic hepatitis C with recombinant interferon alfa (rIFN-alpha) can cause a decrease of serum transaminases and hepatitis C virus (HCV) RNA. Recent trials evaluating combination therapy of IFN-alpha and ribavirin suggested a potential synergistic effect. From serial meas

Effect of interferon alfa on the dynamic
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
✍ S Zeuzem; J M Schmidt; J Lee; B Ruster; W K Roth πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 233 KB πŸ‘ 1 views

recently published data on human immunodeficiency vi-In about 30% to 40% of patients with chronic hepatitis rus type 1 (HIV-1) suggesting that both RNA viruses rep-C, treatment with recombinant interferon alfa (r-IFNa) licate continuously and highly productive in vivo. The causes a decrease of serum

Therapy of hepatitis C: Interferon alfa-
Therapy of hepatitis C: Interferon alfa-2a trials
✍ W M Lee πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 183 KB πŸ‘ 2 views

Interferon alfa-2a resembles other recombinant alpha inter-2a has recently been approved by the Food and Drug Administration for use as therapy of chronic hepatitis C in a regimen ferons in structure and pharmacology. Studies delineating its efficacy suggest that after 6 to 12 months of therapy, sus